SITC 2023 PBMC Humanized Mouse Model with Clinical Relevance in Assessing the Safety Profile of 4-1BB Agonist, Urelumab, in 5 Donors Published Date October 30, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen